We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to BCR

BCR — TMED7

Text-mined interactions from Literome

Gesbert et al., J Biol Chem 2000 : We demonstrate that the decrease of p27 ( Kip1 ) is directly due to BCR/ABL in hematopoietic cells by two different approaches ... The PI3K inhibitor LY-294002 blocks the ability of BCR/ABL to induce p27 ( Kip1 ) down-regulation and inhibits BCR/ABL induced entry into S phase ... Overall, these data are consistent with a model in which BCR/ABL suppresses p27 ( Kip1 ) protein levels through PI3K/AKT, leading to accelerated entry into S phase
Banerji et al., Oncogene 2001 (Lymphoma, B-Cell...) : We show that BCR stimulation of WEHI 231 cells results in down-regulation of cyclin D2 and up-regulation of p27 ( Kip1 ), which are associated with pocket protein hypophosphorylation and E2F inactivation
Fan et al., Chin Med J (Engl) 2001 (Leukemia, Myelogenous, Chronic, BCR-ABL Positive) : In this model, we showed that the presence of p210BCR/ABL leads to elevated levels of p27kip in p210BCR/ABL expressing CD34+ cells
Schuster et al., Blood 2003 : In contrast, the up-regulation of PU.1 and p27 ( Kip1 ) by G-CSF was not affected by Bcr-Abl
Andreu et al., Cancer Res 2005 (Leukemia, Myelogenous, Chronic, BCR-ABL Positive) : We further show that BCR-ABL also regulates p27 ( Kip1 ) protein levels by increasing its degradation by the proteasome ... In conclusion, these results suggest that BCR-ABL regulates cell cycle in CML cells at least in part by inducing proteasome mediated degradation of the cell cycle inhibitor p27 ( Kip1 ) and provide a rationale for the use of inhibitors of the proteasome in patients with BCR-ABL leukemias
Rangatia et al., Leukemia 2006 (Leukemia, Myelogenous, Chronic, BCR-ABL Positive) : Lack of BCR-ABL leads to cell cycle arrest in G1 phase as observed by decrease in cyclin D1 and increase in p21 and p27 cdk inhibitors mRNA
Craxton et al., Eur J Immunol 2007 : Likewise, BCR induced p27 ( Kip1 ) degradation was decreased in Bim KO compared to WT B cells
Richards et al., Eur J Immunol 2009 : BCR ligation leads to a more rapid decrease in p27 ( Kip1 ) levels in gp91(phox) KO B cells